Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 33,500 | |||
5 mg | 在庫あり | ¥ 80,500 | |||
10 mg | 在庫あり | ¥ 122,000 | |||
25 mg | 在庫あり | ¥ 197,500 | |||
50 mg | 在庫あり | ¥ 271,000 | |||
100 mg | 在庫あり | ¥ 365,000 | |||
500 mg | 在庫あり | ¥ 732,500 |
説明 | Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema. |
別名 | LF220542, LF 220542, LF 22-0542, LF-220542, LF-22-0542, LF22-0542 |
分子量 | 502.63 |
分子式 | C25H34N4O5S |
CAS No. | 633698-99-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (99.48 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Safotibant 633698-99-4 GPCR/G Protein Bradykinin Receptor LF220542 LF 220542 LF 22-0542 LF-220542 LF-22-0542 LF22-0542 Inhibitor inhibitor inhibit